Brookdale Senior Living Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Brookdale Senior Living Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $986.64M | Feb 19, 2020 |
| FY2019 | Sep 30, 2019 | $1.01B | Feb 19, 2020 |
| FY2019 | Jun 30, 2019 | $1.02B | Feb 19, 2020 |
| FY2019 | Mar 31, 2019 | $1.04B | Feb 19, 2020 |
| FY2019 | Dec 31, 2018 | $1.07B | Feb 19, 2020 |
| FY2019 | Sep 30, 2018 | $1.12B | Feb 19, 2020 |
| FY2019 | Jun 30, 2018 | $1.16B | Feb 19, 2020 |
| FY2019 | Mar 31, 2018 | $1.19B | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $1.17B | Feb 14, 2019 |
| FY2018 | Sep 30, 2017 | $1.18B | Feb 14, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.19B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $3.13B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $3.02B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $2.83B | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $2.76B | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $3.54B | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $4.06B | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | $4.53B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $4.75B | Feb 19, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $837.55M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $799.31M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $746.70M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $594.41M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $500.95M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $797.15M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $876.54M | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | $1.07B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $1.25B | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $1.44B | Feb 14, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($262.69M) | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | ($201.94M) | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | ($189.01M) | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | ($238.43M) | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | ($99.29M) | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $82.02M | Feb 22, 2023 |
| FY2019 | Dec 31, 2019 | ($91.41M) | Feb 19, 2020 |
| FY2019 | Sep 30, 2019 | ($78.46M) | Feb 19, 2020 |
| FY2019 | Jun 30, 2019 | ($55.47M) | Feb 19, 2020 |
| FY2019 | Mar 31, 2019 | ($42.60M) | Feb 19, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.50M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $46.53M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $18.41M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | ($42.69M) | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | ($216.94M) | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | ($97.69M) | Feb 22, 2023 |
| FY2019 | Dec 31, 2019 | ($43.15M) | Feb 19, 2020 |
| FY2019 | Sep 30, 2019 | ($20.22M) | Feb 19, 2020 |
| FY2019 | Jun 30, 2019 | $2.21M | Feb 19, 2020 |
| FY2019 | Mar 31, 2019 | $16.66M | Feb 19, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $218.03M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $166.18M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $162.92M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $3.28M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | ($94.63M) | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $205.65M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $216.41M | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | $203.96M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $378.36M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $373.65M | Feb 14, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $201.53M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $201.25M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $233.21M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $196.92M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $176.66M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $185.87M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $304.09M | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | $225.47M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $213.89M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $333.65M | Feb 14, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.95B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $6.34B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $5.57B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $5.94B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $6.41B | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $6.90B | Feb 15, 2022 |
| FY2020 | Dec 31, 2019 | $7.19B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $6.47B | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $7.68B | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | $9.22B | Feb 22, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.00B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $6.12B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $5.17B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $5.35B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $5.71B | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $6.10B | Feb 15, 2022 |
| FY2020 | Dec 31, 2019 | $6.50B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $5.45B | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $6.15B | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | $7.14B | Feb 22, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($44.75M) | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $212.48M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $403.66M | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $582.61M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $697.40M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $800.43M | Feb 15, 2022 |
| FY2020 | Dec 31, 2019 | $696.36M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $1.02B | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $1.53B | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | $2.08B | Feb 22, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $27.32M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $27.32M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $27.32M | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $27.32M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $27.32M | Feb 22, 2023 |
| FY2022 | Jan 1, 2021 | $154.10M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $154.13M | Feb 15, 2022 |
| FY2020 | Dec 31, 2019 | $154.13M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $154.13M | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $505.78M | Feb 14, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($4.30B) | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | ($4.04B) | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | ($3.84B) | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | ($3.65B) | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | ($3.41B) | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | ($3.31B) | Feb 15, 2022 |
| FY2020 | Dec 31, 2019 | ($3.39B) | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | ($3.07B) | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | ($2.54B) | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | ($1.97B) | Feb 22, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $279.12M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $308.93M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $277.97M | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $398.85M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $347.03M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $380.42M | Feb 15, 2022 |
| FY2020 | Dec 31, 2019 | $240.23M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $398.27M | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $222.65M | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | $216.40M | Feb 22, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.29B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $4.06B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $3.70B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $3.85B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $3.84B | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $3.92B | Feb 15, 2022 |
| FY2020 | Dec 31, 2019 | $3.56B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $3.64B | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $5.14B | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | $6.05B | Feb 22, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | (1) | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | (1) | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | (2) | Feb 25, 2021 |
| FY2013 | Dec 31, 2013 | 0 | Mar 3, 2014 |
| FY2013 | Sep 30, 2013 | 0 | Mar 3, 2014 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | (1) | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | (1) | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | (2) | Feb 25, 2021 |
| FY2013 | Dec 31, 2013 | 0 | Mar 3, 2014 |
| FY2013 | Sep 30, 2013 | 0 | Mar 3, 2014 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 237.75M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 200.02M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | 188.25M | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | 187.25M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | 186.96M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | 187.80M | Feb 15, 2022 |
| FY2020 | Dec 31, 2019 | 192.13M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | 192.36M | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | 191.28M | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | 190.05M | Feb 22, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2010 | Dec 31, 2010 | $0 | Feb 28, 2011 |
| FY2010 | Dec 31, 2009 | $0 | Feb 28, 2011 |
| FY2010 | Dec 31, 2008 | $129.46M | Feb 28, 2011 |